[1. Adams V.J., Evans K.M., Sampson J., Wood J.L.: Methods and mortality results of a health survey of purebred dogs in the UK. J Small Anim Pract 2010, 51, 512–524.10.1111/j.1748-5827.2010.00974.x21029096]Search in Google Scholar
[2. Arendt M.L., Melin M., Tonomura N., Koltookian M., Courtay-Cahen C., Flindall N., Bass J., Boerkamp K., Megquir K., Youell L., Murphy S., McCarthy C., London C., Rutteman G.R., Starkey M., Lindblad-Toh K.: Genome-wide association study of Golden Retrievers identifies germ-line risk factors predisposing to mast cell tumours. PLoS Genet 2015, 11, e1005647.10.1371/journal.pgen.1005647465448426588071]Search in Google Scholar
[3. Blackwood L., Murphy S., Buracco P., de Vos J.P., de Fornel-Thibaud P., Hirschberger J., Kessler M., Pastor J., Ponce F., Savary-Bataille K., Argyle D.J.: European consensus document on mast cell tumours in dogs and cats. Vet Comp Oncol 2012, 10, e1–e29.10.1111/j.1476-5829.2012.00341.x22882486]Search in Google Scholar
[4. Boerkamp K.M., Teske E., Boon L.R., Grinwis G.C., van den Bossche L., Rutteman G.R.: Estimated incidence rate and distribution of tumours in 4,653 cases of archival submissions derived from the Dutch golden retriever population. BMC Vet Res 2014, 31, 10–34.10.1186/1746-6148-10-34391470824484635]Search in Google Scholar
[5. Davis B.W., Ostrander E.A.: Domestic dogs and cancer research: a breed-based genomics approach. ILAR J 2014, 55, 59–68.10.1093/ilar/ilu017415834624936030]Search in Google Scholar
[6. Dobson J.M.: Breed-predispositions to cancer in pedigree dogs. ISRN Vet Sci 2013, ID: 941275, doi:10.1155/2013/941275.10.1155/2013/941275365842423738139]Search in Google Scholar
[7. Dobson J.M., Scase T.J.: Advances in the diagnosis and management of cutaneous mast cell tumours in dogs. J Small Anim Pract 2007, 48, 424–431.10.1111/j.1748-5827.2007.00366.x17559522]Search in Google Scholar
[8. Egenvall A., Bonnett B.N., Hedhammar A., Olson P.: Mortality in over 350,000 insured Swedish dogs from 1995–2000: II. Breed-specific age and survival patterns and relative risk for causes of death. Acta Vet Scand 2005, 46, 121–136.10.1186/1751-0147-46-121162481816261925]Search in Google Scholar
[9. Erich S.A., Constantino-Casas F., Dobson J.M., Teske E.: Morphological distinction of histiocytic sarcoma from other tumor types in Bernese Mountain Dogs and Flatcoated Retrievers. In Vivo 2018, 32, 7–17.10.21873/invivo.11198589262629275293]Search in Google Scholar
[10. Grüntzig K., Graf R., Boo G., Guscetti F., Hässig M., Axhausen K.W., Fabrikant S., Welle M., Meier D., Folkers G., Pospischil A.: Swiss Canine Cancer Registry 1955–2008: occurrence of the most common tumour diagnoses and influence of age, breed, body size, sex, and neutering status on tumour development. J Comp Pathol 2016, 155, 156–170.10.1016/j.jcpa.2016.05.01127406312]Search in Google Scholar
[11. Grüntzig K., Graf R., Hassig M., Welle M., Meier D., Lott G., Erni D., Schenker N.S., Guscetti F., Boo G., Axhausen K., Fabrikant S., Folkers G., Pospischil A.: The Swiss Canine Cancer Registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol 2015, 152, 161–171.10.1016/j.jcpa.2015.02.00525824119]Search in Google Scholar
[12. Kandefer-Gola M., Nowak M., Madej J.A., Dzimira S., Ciaputa R., Janus I.: Useful immunohistochemical indicators in canine mast cell tumours Act Vet Hung 2015, 63, 49–59.10.1556/avet.2015.005]Search in Google Scholar
[13. Kandefer-Gola M., Nowak M., Dzimira S., Janus I., Ciaputa R., Madej J.A.: COX-2 and mPGES-1 expression in canine mast cell tumour. Med Weter 2015 71, 345–348.10.1016/j.jcpa.2014.10.101]Search in Google Scholar
[14. Kandefer-Gola M., Madej J.A., Dzimira S., Nowak M., Janus I., Ciaputa R.: Comparative analysis of markers of cell proliferation in canine mast cell tumour according to current classifications. Pol J Vet Sci 2015, 18, 241–247.10.1515/pjvs-2015-003126172171]Search in Google Scholar
[15. Kandefer-Gola M., Madej J.A., Dzimira S., Janus I., Nowak M., Ciaputa R.: Immunohistochemical evaluation of neoangiogenesis in canine mast cell tumours. Bull Vet Inst Pulawy 2015, 59, 247–253.10.1515/bvip-2015-0037]Search in Google Scholar
[16. Kiupel M., Webster J.D., Bailey K.L., Best S., DeLay J., Detrisac C.J., Fitzgerald S.D., Gamble D., Ginn P.E., Goldschmidt M.H., Hendrick M.J., Howerth E.W., Janovitz E.B., Langohr I., Lenz S.D., Lipscomb T.P., Miller M.A., Misdorp W., Moroff S., Mullaney T.P., Neyens I., O’Toole D., Ramos-Vara J., Scase T.J., Schulman F.Y., Sledge D., Smedley R.C., Smith K., Snyder P., Southorn E., Stedman N.L., Steficek B.A., Stromberg P.C., Valli V.E., Weisbrode S.E., Yager J., Heller J., Miller R.: Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol 2011, 48, 147–155.10.1177/0300985810386469836984921062911]Search in Google Scholar
[17. Krupa A., Hildebrand W., Kandefer-Gola M., Nowak M., Nicpoń J.: Mast cell tumor. Med Weter 2013, 69, 102–108.]Search in Google Scholar
[18. Leidinger E.F., Freeman K., Kirtz G., Hooijberg E.H., Sick K.: Breed related odds ratio and anatomic distribution of canine mast cell tumours in Austria. Retrospective study of cases in the years 2000–2010. Tierarztl Prax Ausg K Kleintiere Heimtiere 2014, 42, 367–373.10.15654/TPK-14016525418504]Search in Google Scholar
[19. Miller D.M.: The occurrence of mast cell tumors in young Shar-Peis. J Vet Diagn Invest 1995, 7, 360–363.10.1177/1040638795007003117578452]Search in Google Scholar
[20. Mochizuki H., Motsinger-Reif A., Bettini C., Moroff S., Breen M.: Association of breed and histopathological grade in canine mast cell tumours. Vet Comp Oncol 2017, 15, 829–839.10.1111/vco.1222527198171]Search in Google Scholar
[21. O’Connell K., Thomson M.: Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases. Vet Comp Oncol 2013, 11, 51–62.10.1111/j.1476-5829.2011.00301.x22235766]Search in Google Scholar
[22. O’Neill D.G., Church D.B., McGreevy P.D., Thomson P.C., Brodbelt D.C.: Longevity and mortality of owned dogs in England. Vet J 2013, 198, 638–643.10.1016/j.tvjl.2013.09.02024206631]Search in Google Scholar
[23. Olson K.R., Levy J.K., Norby B., Crandall M.M., Broadhurst J.E., Jacks S., Barton R.C., Zimmerman M.S.: Inconsistent identification of pit bull-type dogs by shelter staff. Vet J 2015, 206, 197–202.10.1016/j.tvjl.2015.07.01926403955]Search in Google Scholar
[24. Patnaik A.K., Ehler W.J., MacEwen E.G.: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984, 21, 469–474.10.1177/0300985884021005036435301]Search in Google Scholar
[25. Pizzoni S., Sabattini S., Stefanello D., Dentini A., Ferrari R., Dacasto M., Giantin M., Laganga P., Amati M., Tortorella G., Marconato L.: Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study. Vet Comp Oncol 2017, 16, 28–36.10.1111/vco.1230628233400]Search in Google Scholar
[26. Polton G.A., Mowat V., Lee H.C., McKee K.A., Scase T.J.: Breed, gender and neutering status of British dogs with anal sac gland carcinoma. Vet Comp Oncol 2006, 4, 125–131.10.1111/j.1476-5829.2006.00100.x19754809]Search in Google Scholar
[27. Shoop S.J., Marlow S., Church D.B., English K., McGreevy P.D., Stell A.J., Thomson P.C., O’Neill D.G., Brodbelt D.C.: Prevalence and risk factors for mast cell tumours in dogs in England. Canine Genet Epidemiol 2015, 2, 1–10.10.1186/2052-6687-2-1457937026401329]Search in Google Scholar
[28. Sledge D.G., Webster J., Kiupel M.: Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis and treatment selection. Vet J 2016, 215, 43–54.10.1016/j.tvjl.2016.06.00327372911]Search in Google Scholar
[29. Śmiech A., Ślaska B., Łopuszyński W., Jasik A., Szczepanik M., Wilkołek P.: Epidemiological study of canine mast cell tumours according to the histological malignancy grade. Pol J Vet Sci 2017, 20, 455–465.10.1515/pjvs-2017-005529166281]Search in Google Scholar
[30. Śmiech A., Ślaska B., Surdyka M., Grzybowska-Szatkowska L., Łopuszyński W., Różańska D.: Identification of additional mitochondrial DNA mutations in canine mast cell tumours. Acta Vet Scand 2016, 58, 2–8.10.1186/s13028-016-0210-y485572227146669]Search in Google Scholar
[31. Villamil J.A., Henry C.J., Bryan J.N., Ellersieck M., Schultz L., Tyler J.W., Hahn A.W.: Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 2011, 239, 960–965.10.2460/javma.239.7.96021961635]Search in Google Scholar
[32. Warland J., Dobson J.: Breed predispositions in canine mast cell tumour: a single centre experience in the United Kingdom. Vet J 2013, 197, 496–498.10.1016/j.tvjl.2013.02.01723583004]Search in Google Scholar
[33. Welle M.M., Bley C.R., Howard J., Rüfenacht S.: Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet Dermatol 2008, 19, 321–339.10.1111/j.1365-3164.2008.00694.x18980632]Search in Google Scholar
[34. White C.R., Hohenhaus A.E., Kelsey J., Procter-Gray E.: Cutaneous MCTs: associations with spay/neuter status, breed, body size, and phylogenetic cluster. J Am Anim Hosp Assoc 2011, 47, 210–216.10.5326/JAAHA-MS-562121498594]Search in Google Scholar
[35. Zinc M.C., Farhoody P., Elser S.E., Ruffini L.D., Gibbons T.A., Rieger R.H.: Evaluation of the risk and age of onset of cancer and behavioral disorders in gonadectomized Vizslas. J Am Vet Med Assoc 2014, 244, 309–319.10.2460/javma.244.3.30924432963]Search in Google Scholar